Helen Mogun
Overview
Explore the profile of Helen Mogun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
3969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Hernandez-Diaz S, Bateman B, Gray K, Alt E, Straub L, et al.
Am J Epidemiol
. 2024 Sep;
PMID: 39317693
To study the risk of spontaneous abortion (SAB) or termination using healthcare utilization databases, algorithms to estimate the gestational age (GA) are needed. Using Medicaid data, we developed a hierarchical...
2.
Straub L, Bateman B, Hernandez-Diaz S, Zhu Y, Suarez E, Vine S, et al.
JAMA
. 2024 Aug;
332(10):805-816.
PMID: 39133511
Importance: Buprenorphine combined with naloxone is commonly used to treat opioid use disorders outside of pregnancy. In pregnancy, buprenorphine alone is generally recommended because of limited perinatal safety data on...
3.
Yland J, Huybrechts K, Wesselink A, Straub L, Chiu Y, Seely E, et al.
Diabetes Care
. 2024 Jul;
47(9):1688-1695.
PMID: 39042587
Objective: We emulated a modified randomized trial (Metformin in Women With Type 2 Diabetes in Pregnancy [MiTy]) to compare the perinatal outcomes in women continuing versus discontinuing metformin during pregnancy...
4.
Hernandez-Diaz S, Straub L, Bateman B, Zhu Y, Mogun H, Wisner K, et al.
N Engl J Med
. 2024 Mar;
390(12):1069-1079.
PMID: 38507750
Background: Maternal use of valproate during pregnancy has been associated with an increased risk of neurodevelopmental disorders in children. Although most studies of other antiseizure medications have not shown increased...
5.
Suarez E, Bateman B, Hernandez-Diaz S, Straub L, McDougle C, Wisner K, et al.
JAMA Psychiatry
. 2024 Jan;
81(5):477-488.
PMID: 38265792
Importance: Use of medications for attention-deficit/hyperactivity disorder (ADHD) during pregnancy is increasing in the US. Whether exposure to these medications in utero impacts the risk of neurodevelopmental disorders in children...
6.
Suarez E, Bateman B, Straub L, Hernandez-Diaz S, Jones H, Gray K, et al.
JAMA Intern Med
. 2024 Jan;
184(3):242-251.
PMID: 38252426
Importance: Use of buprenorphine or methadone to treat opioid use disorder is recommended in pregnancy; however, their teratogenic potential is largely unknown. Objective: To compare the risk of congenital malformations...
7.
Broms G, Hernandez-Diaz S, Huybrechts K, Bateman B, Kristiansen E, Einarsdottir K, et al.
J Clin Psychiatry
. 2023 Jan;
84(1).
PMID: 36652686
Most research on safety of attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy concerns central nervous system stimulants, while little is known about the safety of atomoxetine, a primary treatment alternative. We...
8.
Zhu Y, Thai T, Hernandez-Diaz S, Bateman B, Winterstein A, Straub L, et al.
Epidemiology
. 2022 Dec;
34(1):69-79.
PMID: 36455247
Background: While healthcare utilization data are useful for postmarketing surveillance of drug safety in pregnancy, the start of pregnancy and gestational age at birth are often incompletely recorded or missing....
9.
Suarez E, Huybrechts K, Straub L, Hernandez-Diaz S, Jones H, Connery H, et al.
N Engl J Med
. 2022 Nov;
387(22):2033-2044.
PMID: 36449419
Background: Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data...
10.
Suarez E, Bateman B, Hernandez-Diaz S, Straub L, Wisner K, Gray K, et al.
JAMA Intern Med
. 2022 Oct;
PMID: 36190722
Importance: Antidepressant use during pregnancy has been associated with neurodevelopmental disorders in children in some studies. However, results may be explained by uncontrolled confounding by parental mental health status, genetics,...